Our CEO, Noor Shaker, is giving a keynote at Pharma R&D Informatics, Medicinal Chemistry and Cannabinoids Summit. The talk will cover challenges and opportunities for AI in drug discovery and how our platform Rosalind addresses existing challenges open new possibilities for the discovery of novel chemistry.
top of page
Recent Posts
See AllCombination Accelerates Outcomes in Early Drug Discovery WALTHAM, Mass.; Oct. 28, 2021 – X-Chem, the pioneer of DNA-encoded library (DEL) technology and a recognized leader in generating actionable re
We participated in BioTrinity 2021. This is the first in-person meeting we are attending this year, we are very much looking forward for many to come. Our CEO, Noor Shaker, presented our recent progre
London-based GlamorousAI Secures Grant From Innovate UK to Fund a £440k Project toward Development of New Treatments For Glioblastoma Multiforme. GlamorousAI, a leading artificial intelligence biotech
bottom of page